Company intelligence / Profile preview

Wuling

Fuzhou, Fujian, China

Ownership: Private
Development stage: Other

Overview

Wuling (Fuzhou) Biotechnology is an active Chinese biotech group that manufactures and sells medicinal mushroom-based products, primarily Reishi, as nutraceuticals and dietary supplements. Their flagship 'Wuling capsule' has clinical evidence from China supporting its use as an adjunct to antidepressants for improving insomnia, anxiety, and depressive symptoms, demonstrating strong efficacy and safety, particularly in adolescents.

Therapeutic areas: ImmunologyPsychiatryOther
Modalities: BiologicNatural product
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Wuling.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuling.

Explore the full profile